Azatadine IUPAC nomenclature 11-(1-Methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine Classification H1-receptor antihistamine Piperidine derivative antihistamine drug Physiochemical Properties S. NO. PHYSICAL AND CHEMICAL PROPERTIES 1 Molecular weight 290.4 g/mol 2 Physical appearance Solid 3 Melting point 152-154oC 4 Solubility Very Soluble 5 Octanol/water partition […]
Cimetidine IUPAC nomenclature 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine Classification H2-antihistamine Antiulcer drug Physiochemical Properties S. NO. PHYSICAL AND CHEMICAL PROPERTIES 1 Molecular weight 252.34g/mol 2 Physical appearance White crystalline solid 3 Melting point 142oC 4 Solubility Soluble in alcohol 5 Octanol/water partition coefficient […]
Famotidine IUPAC nomenclature 3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide Classification H2-antihistamine Antiulcer drug Physiochemical Properties S. NO. PHYSICAL AND CHEMICAL PROPERTIES 1 Molecular weight 337.5 g/mol 2 Physical appearance White to pale yellow crystals 3 Melting point 163.5oC 4 Solubility Freely soluble in glacial […]
Omeprazole IUPAC nomenclature 5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-benzimidazole Classification Proton pump inhibitors Physiochemical Properties S. NO. PHYSICAL AND CHEMICAL PROPERTIES 1 Molecular weight 345.4 g/mol 2 Physical appearance White to off-white crystalline powder 3 Melting point 155 oC 4 Solubility Very slightly soluble in […]
Esomeprazole IUPAC nomenclature (S)-(−)-5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-3H-benzoimidazole Classification Proton pump inhibitors Physiochemical Properties S. NO. PHYSICAL AND CHEMICAL PROPERTIES 1 Molecular weight 345.4 g/mol 2 Physical appearance Solid 3 Melting point 155 oC 4 Solubility Very soluble in water 5 Octanol/water […]
Lansoprazole IUPAC nomenclature 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole Classification Proton pump inhibitors Physiochemical Properties S. NO. PHYSICAL AND CHEMICAL PROPERTIES 1 Molecular weight 369.4 g/mol 2 Physical appearance White to brownish-white crystalline powder 3 Melting point 178-182oC 4 Solubility Freely soluble in dimethylformamide; insoluble […]
Dexlansoprazole IUPAC nomenclature (R)-(+)-2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole Classification Proton pump inhibitors Physiochemical Properties S. NO. PHYSICAL AND CHEMICAL PROPERTIES 1 Molecular weight 369.4 g/mol 2 Physical appearance White to brownish-white crystalline powder 3 Melting point 140oC 4 Solubility 0.21 mg/ml 5 Octanol/water […]
Rabeprazole IUPAC nomenclature (RS)-2-([4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl)-1H-benzo[d]imidazole. Classification Proton pump inhibitors Physiochemical Properties S. NO. PHYSICAL AND CHEMICAL PROPERTIES 1 Molecular weight 359.4 g/mol 2 Physical appearance White to yellowish white solid 3 Melting point 99-100oC 4 Solubility Very soluble in water […]
Pantoprazole IUPAC nomenclature (RS)-6-(Difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzo[d]imidazole Classification Proton pump inhibitors Physiochemical Properties S. NO. PHYSICAL AND CHEMICAL PROPERTIES 1 Molecular weight 383.4 g/mol 2 Physical appearance Off-white solid 3 Melting point 139-140oC 4 Solubility Freely soluble in water 5 Octanol/water […]